Application of a New Subretinal Injection Device in the Dog
- 1 July 2006
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 15 (6) , 511-519
Abstract
The use of a new subretinal injection device (RetinaJect™ Subretinal Cannula, SurModics, Inc., Eden Prairie, MN) to access the subretinal space in the canine model was evaluated. Subretinal injections were performed in 33 mongrel dogs between 2 and 52 months of age (median = 9 months). In 5 normal dogs the injection of 150 μl saline or India ink occurred by using a conventional subretinal injection device (CSID) with a 30-gauge anterior chamber irrigating cannula. The sclera had to be surgically exposed and penetrated before the subretinal injection with the CSID could occur. After removing the CSID, the conjunctiva over the sclerotomy site had to be closed. In a second group of 28 dogs [16 normals, 10 RPE65 mutants, and 2 with progressive rod cone degeneration (prcd)], the 25-gauge needle of the RetinaJect™ was used to penetrate the conjunctiva and the sclera. Once the tip of the needle was close to the retinal surface, a 39-gauge polyimide cannula was extended and brought into apposition with the retina for the subsequent subretinal injection of 150 μl saline, India ink, or adeno-associated virus (AAV). No closure of the conjunctiva was required. The animals were clinically monitored between 1 and 59 weeks after surgery. From this second group 25 eyes were harvested for routine histological analysis either immediately after surgery or after a clinical observation time of between 1 and 40 weeks. Both devices provided equally successful access to the subretinal space. The main advantage of the RetinaJect™ was that no surgical dissection was required; this led to a shorter procedure time and milder postoperative conjunctival swelling. In summary, the use of the RetinaJect™ can be recommended as an alternative to the CSID for subretinal injections in dogs.Keywords
This publication has 13 references indexed in Scilit:
- Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood BlindnessMolecular Therapy, 2005
- AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosaMolecular Therapy, 2003
- Gene therapy restores vision in a canine model of childhood blindnessNature Genetics, 2001
- Posterior Segment Approach for Subretinal Transplantation or Injection in the Canine ModelCell Transplantation, 2001
- Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapyNature Genetics, 2000
- [50] Cross-species comparison of in vivo reporter gene expression after recombinant adeno-associated virus-mediated retinal transduction2000
- Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAVVision Research, 1999
- Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degenerationHuman Molecular Genetics, 1998
- Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapyNature Medicine, 1996
- Variation in retinal degeneration phenotype inherited at the prcd locusExperimental Eye Research, 1988